| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥36.15 |
| 52 Week High | CN¥38.03 |
| 52 Week Low | CN¥29.31 |
| Beta | 0.031 |
| 1 Month Change | 3.88% |
| 3 Month Change | 6.26% |
| 1 Year Change | 18.91% |
| 3 Year Change | 33.25% |
| 5 Year Change | 53.76% |
| Change since IPO | 1,973.54% |
Recent News & Updates
Shareholder Returns
| 2223 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 4.6% | -2.4% | -0.2% |
| 1Y | 18.9% | -23.1% | -17.8% |
Return vs Industry: 002223 exceeded the CN Medical Equipment industry which returned -23.1% over the past year.
Return vs Market: 002223 exceeded the CN Market which returned -17.8% over the past year.
Price Volatility
| 2223 volatility | |
|---|---|
| 2223 Average Weekly Movement | 4.5% |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 002223 has not had significant price volatility in the past 3 months.
Volatility Over Time: 002223's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 6,362 | Qun Wu | www.yuyue.com.cn |
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. engages in the manufacture and sale of medical devices in China and internationally. The company offers respiratory solutions, including single and bi-level PAP, breathwear masks, oxygen concentrators, high flow nasal cannula oxygen therapy, nebulizers, and suction apparatus; blood pressure and glucose systems; infrared, infrared ear, and medical digital thermometers; oximeters; and wheelchairs and electric wheelchairs.
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Fundamentals Summary
| 2223 fundamental statistics | |
|---|---|
| Market cap | CN¥35.68b |
| Earnings (TTM) | CN¥2.65b |
| Revenue (TTM) | CN¥8.65b |
13.5x
P/E Ratio4.1x
P/S RatioIs 2223 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2223 income statement (TTM) | |
|---|---|
| Revenue | CN¥8.65b |
| Cost of Revenue | CN¥4.22b |
| Gross Profit | CN¥4.43b |
| Other Expenses | CN¥1.78b |
| Earnings | CN¥2.65b |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 27, 2024
| Earnings per share (EPS) | 2.68 |
| Gross Margin | 51.23% |
| Net Profit Margin | 30.64% |
| Debt/Equity Ratio | 10.2% |
How did 2223 perform over the long term?
See historical performance and comparison